Martin Stuart, PhD
President & CEO
Martin Stuart, PhD, is a serial entrepreneur who has enjoyed more than 30 years of commercial success introducing new and complex technologies to the Life Science and Healthcare markets.
Operating largely at the intersection of science and business, Martin’s forte is transforming technology-driven companies into market-driven organizations with solid business acumen. No stranger to the start-up world, he has taken two companies from inception to $50+M and ultimately exit through acquisition or public markets. He has built and managed sales channels in more than 40 countries around the world, delivering commercial success.
Dr. Stuart spent 8+ years with Aperio Technologies, where he was responsible for building commercial operations including sales, marketing and services. He championed several key initiatives such as the Pathology Visions Conference, now the largest digital pathology industry conference in the world, and also fostered the collaboration to digitize the world famous pathology slide collection from Dr. Juan Rosai. These initiatives, coupled with solid, sustained, commercial growth, propelled Aperio to be the undisputed leader in the global digital pathology market. Aperio was acquired by Leica Biosystems, a Danaher Company, in 2012.
Dr. Stuart was awarded a PhD from The University College of North Wales for his work on Ultra-High-Resolution Imaging of Langmuir Blodgett films and a BSc in Physics from London South Bank University, England.
Chief Technology Officer
Victor is Mikroscan’s Co-Founder and Chief Technology Officer. He has been involved in the microscopy industry for over 30 years and has deep technical experience in high performance and histology-based microcopy techniques.
Victor’s career started with McBain Instruments, a provider of specialized microscopy products, as a service technician and photomicrography expert. In this role he became expert in the creation of 35mm and Polaroid “photowalls”- early predecessors to modern large-format digital pathology images. Victor went on to work in McBain’s Special Products and Engineering Departments where he developed the Papnet Cytology Quality Assurance system and digital imaging technology used to record histology-based tissue block faces with sections on individual slides. Further work with McBain Instruments resulted in custom solutions for high performance microscopy applications like 3D confocal imaging, deconvolution, calcium ratiometric imaging, GFP, fluorescence and brain mapping. Victor’s microscopy solutions are found in prestigious institutions such as the Gonda (Goldschmeid) Neuroscience and Genetics Institute and Brain Research Institute, both at University of California- Los Angeles.
Victor’s interest and involvement in histology-based digital imaging led him to co-found Mikroscan, where he has been named the primary inventor on two submitted patents, and one provisional patent for network-based pathology with a desktop imaging slide scanner.
Vice President of Engineering and Operations
Jeff Gray has more than 25 years of management experience ranging from small startup companies to Fortune 100 firms. He has two decades of product development and operations management experience as president/head of technology for a test equipment manufacturing firm, and as vice president of operations for a medical device manufacturer. He has held many management-level roles at companies such as CareFusion (formerly Cardinal Health/Pyxis/Alaris) in the fields of product development, manufacturing, reliability engineering, and regulatory compliance.
Jeff also managed the test laboratory and staff for the North American operations of a European Notified Body (Nemko), and is an expert in creating and maintaining high-functioning quality management systems (ISO 13485 and ISO 9000), including Risk Management, and FDA GMP (21 CFR 820). He has employed his Lean and Design for Six Sigma training to scale in-house manufacturing operations in a startup company ($20k/mo) to mid-volume production ($500k/mo) over a period of 12 months.
Jeff holds an MBA from Indiana University Kelley School of Business, a Master’s Degree in Engineering from Purdue University, and a Bachelor’s Degree in Electrical Engineering from San Diego State University. He is a Certified Lean Six Sigma Master Black Belt by Ohio State University Fisher College of Business, and maintains a Professional Engineering License in the State of California (electrical). Jeff is the holder of six U.S. patents, with other patents pending.
Software Engineering Manager
James Crowe is a seasoned IT professional with over 15 years of software development experience and is the principal architect for Mikroscan’s software products. An expert in electro-optical software control systems for various digital imaging devices, James was instrumental in the development of Mikroscan’s flagship product the SL5.
Prior to joining Mikroscan, James served as a database analyst/programmer at Synteract, supporting Phase I-IV clinical trials for biotech and pharmaceutical industries. He successfully lead numerous rescue studies for major pharmaceutical companies.
James was awarded both his BS and MS degrees in Computer Science from California State University San Marcos.
Danielle Pirain joins Mikroscan as an Application Specialist with over 15 years in the pathology lab setting. Prior to coming to Mikroscan, she has worked as a pathologist assistant, MOHS histologist and researcher in established institutions such as Cleveland Clinic Foundation and the University of Pittsburgh Medical Center. Her research concentration was on patient safety and pathology process improvement. She is an ASCP certified Medical Technologist and a member of the ASMH.
Technical Operations Supervisor
Adam Uribe is responsible for all technical aspects of final assembly, calibration and system validation. In addition, Adam’s analytical and diagnostic skills make him a key member of the client services team.
An accomplished biotechnology professional, Adam has more than 20 years experience in research and product development in both academic and private sectors.
Adam started his career in academia within the Department of Medicine, University of California, San Diego, studying transcription factors in early mammalian embryogenesis. He managed a dedicated facility producing transgenic and chimeric mouse lines. In addition, as a cost containment initiative, Adam established an in-house cryogenics facility.
He has worked for numerous organizations in roles of increasing responsibility, including Hybritech, Nanogen, JMAR Technologies and Medipacs.
A San Diego native, Adam holds a Bachelor’s Degree in Biology from University of California San Diego.